Company intelligence / Profile preview

A&J Science

South Korea

Ownership: Private
Development stage: Other

Overview

A&J Science is advancing two pre-clinical candidates targeting intractable bacterial diseases (C. difficile infection and NTM pulmonary disease) to IND-enabling studies, supported by multiple international grants. Additional programs target MRSA.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

2 assets

AJ-099(I)

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Collaborations with three academic/commercial partners in Switzerland, Sweden, and France via Eurostars-3 grant

Beyond the preview

Go deeper on A&J Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A&J Science.

Explore the full profile